Edges in Network
Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
Node | RPL36AP51///RPL36A |
Upstream (Parents) |
---|
(<<) NFE2L3 → RPL36AP51///RPL36A |
(<<) SLC25A24 → RPL36AP51///RPL36A |
(<<) MST4 → RPL36AP51///RPL36A |
(<<) SLC25A6 → RPL36AP51///RPL36A |
(<<) RPL29P11///RPL29P15///RPL29P9///RPL29P26///RPL29P6///RPL29P4///RPL29P31///RPL29P12///RPL29 → RPL36AP51///RPL36A |
(<<) IGBP1 → RPL36AP51///RPL36A |
(<<) UGP2 → RPL36AP51///RPL36A |
Downstream (Children) |
---|
RPL36AP51///RPL36A → FAIM2 (>>) |
RPL36AP51///RPL36A → AP4E1 (>>) |
RPL36AP51///RPL36A → C16orf71 (>>) |
RPL36AP51///RPL36A → DHX58 (>>) |
RPL36AP51///RPL36A → CAMK2B (>>) |
RPL36AP51///RPL36A → RHD (>>) |
RPL36AP51///RPL36A → DIO3 (>>) |
RPL36AP51///RPL36A → ZSCAN2 (>>) |
RPL36AP51///RPL36A → MST4 (>>) |
RPL36AP51///RPL36A → RPS4XP3 (>>) |
RPL36AP51///RPL36A → SLC25A6 (>>) |
RPL36AP51///RPL36A → RPS14P3///RPS14 (>>) |
RPL36AP51///RPL36A → RPL29P11///RPL29P15///RPL29P9///RPL29P26///RPL29P6///RPL29P4///RPL29P31///RPL29P12///RPL29 (>>) |
RPL36AP51///RPL36A → IGBP1 (>>) |